CD4 and COVID-19: Supporting this, we found B cell and CD4 T cell pathways enriched in ChAdOx1 nCoV-19 vaccinees compared with controls at COVID-19 onset, revealing rapid, vaccine-induced anti-SARS-CoV-2 adaptive immune responses captured in real-time.